AI Assistant
Blog
Pricing
Log In
Sign Up
Pregnancy outcome after early exposure to nivolumab, a PD-1 checkpoint inhibitor for relapsed Hodgkin’s lymphoma
Details
Cite
Export
Add to List
This content is not available in your region!
Continue researching
here.
